Table 2.
Characteristics of incident UTI cases from 2016 to 2019 by sex and age groupa based on all incident UTI cases during the study period
| Total | Sex | Age group | |||||
|---|---|---|---|---|---|---|---|
| (N = 38,099) | Female (N = 29,483) | Male (N = 8,616) | 0–5 years (N = 904) | 6–13 years (N = 1,122) | 14–17 years (N = 1,019) |
> = 18 years (N = 35,054) |
|
| Age group in years | (N = 38,099) | (N = 29,483) | (N = 8,616) | (N = 904) | (N = 1,122) | (N = 1,019) | (N = 35,054) |
| 0–5 | 904 (2.4%) | 715 (2.4%) | 189 (2.2%) | 904 (100%) | |||
| 6–13 | 1,122 (2.9%) | 949 (3.2%) | 173 (2.0%) | 1,122 (100%) | |||
| 14–17 | 1,019 (2.7%) | 925 (3.1%) | 94 (1.1%) | 1,019 (100%) | |||
| 18–24 | 3,888 (10.2%) | 3,428 (11.6%) | 460 (5.3%) | 3,888 (11.1%) | |||
| 25–34 | 5,506 (14.5%) | 4,645 (15.8%) | 861 (10.0%) | 5,506 (15.7%) | |||
| 35–44 | 4,121 (10.8%) | 3,306 (11.2%) | 815 (9.5%) | 4,121 (11.8%) | |||
| 45–54 | 4,288 (11.3%) | 3,213 (10.9%) | 1,075 (12.5%) | 4,288 (12.2%) | |||
| 55–64 | 4,258 (11.2%) | 3,062 (10.4%) | 1,196 (13.9%) | 4,258 (12.1%) | |||
| 65–74 | 4,424 (11.6%) | 3,053 (10.4%) | 1,371 (15.9%) | 4,424 (12.6%) | |||
| 75–84 | 5,858 (15.4%) | 4,108 (13.9%) | 1,750 (20.3%) | 5,858 (16.7%) | |||
| 85–94 | 2,481 (6.5%) | 1,893 (6.4%) | 588 (6.8%) | 2,481 (7.1%) | |||
| 95 + | 230 (0.6%) | 186 (0.6%) | 44 (0.5%) | 230 (0.7%) | |||
| Diagnoses | (N = 38,099) | (N = 29,483) | (N = 8,616) | (N = 904) | (N = 1,122) | (N = 1,019) | (N = 35,054) |
| N39.0 | 24,631 (64.6%) | 18,737 (63.6%) | 5,894 (68.4%) | 760 (84.1%) | 902 (80.4%) | 693 (68.0%) | 22,276 (63.5%) |
| N30.0 | 5,511 (14.5%) | 4,158 (14.1%) | 1,353 (15.7%) | 42 (4.6%) | 59 (5.3%) | 101 (9.9%) | 5,309 (15.1%) |
| N30.9 | 5,171 (13.6%) | 4,351 (14.8%) | 820 (9.5%) | 65 (7.2%) | 106 (9.4%) | 148 (14.5%) | 4,852 (13.8%) |
| N10 | 361 (0.9%) | 292 (1.0%) | 69 (0.8%) | 10 (1.1%) | 10 (0.9%) | 4 (0.4%) | 337 (1.0%) |
| Multiple diagnoses | 2,425 (6.4%) | 1,945 (6.6%) | 480 (5.6%) | 27 (3.0%) | 45 (4.0%) | 73 (7.2%) | 2,280 (6.5%) |
| Any antibacterial prescribed?b | (N = 38,099) | (N = 29,483) | (N = 8,616) | (N = 904) | (N = 1,122) | (N = 1,019) | (N = 35,054) |
| Yes | 29,476 (77.4%) | 23,492 (79.7%) | 5,984 (69.5%) | 719 (79.5%) | 881 (78.5%) | 817 (80.2%) | 27,059 (77.2%) |
| Grouped diagnosing physician specialty | (N = 34,038) | (N = 26,314) | (N = 7,724) | (N = 804) | (N = 1,023) | (N = 934) | (N = 31,277) |
| GP | 18,925 (55.6%) | 15,098 (57.4%) | 3,827 (49.5%) | 74 (9.2%) | 174 (17.0%) | 448 (48.0%) | 18,229 (58.3%) |
| Urologist | 6,573 (19.3%) | 3,367 (12.8%) | 3,206 (41.5%) | 29 (3.6%) | 77 (7.5%) | 62 (6.6%) | 6,405 (20.5%) |
| Gynaecologist | 4,864 (14.3%) | 4,852 (18.4%) | 12 (0.2%) | 16 (1.6%) | 116 (12.4%) | 4,732 (15.1%) | |
| Paediatrician | 1,739 (5.1%) | 1,466 (5.6%) | 273 (3.5%) | 685 (85.2%) | 727 (71.1%) | 257 (27.5%) | 70 (0.2%) |
| Other | 453 (1.3%) | 342 (1.3%) | 111 (1.4%) | 5 (0.6%) | 3 (0.3%) | 7 (0.7%) | 438 (1.4%) |
| Multiple specialties | 1,484 (4.4%) | 1,189 (4.5%) | 295 (3.8%) | 11 (1.4%) | 26 (2.5%) | 44 (4.7%) | 1,403 (4.5%) |
| Any antibacterial prescribed by diagnosing specialty?c | (N = 34,038) | (N = 26,314) | (N = 7,724) | (N = 804) | (N = 1,023) | (N = 934) | (N = 31,277) |
| Yes | 24,862 (73.0%) | 20,015 (76.1%) | 4,847 (62.8%) | 636 (79.1%) | 797 (77.9%) | 734 (78.6%) | 22,695 (72.6%) |
ano UTI diagnosed in the 4 quarters preceding the respective quarter
bin the quarter of a UTI diagnosis, by any physician
cin the quarter of a UTI diagnosis, by a physician specialty diagnosing a UTI in the respective quarter
UTI Urinary tract infection